MSB Trading 2021 - paradigm shift, page-61

If this is the case, maybe this approach might be the way to go about getting their pound of flesh rather than the current slow-death by FDA controlled strangulation.

Memo - 9-1 expert panel approval only to be squashed by the same organisation that sent them. pure BS.

ARDS - Advised to ‘stop’ trial due to PROBABILITY of not reaching ~40% reduction compared to placebo group.!!! Pure BS.
Common sense can recognise that in this pandemic to equal the placebo arm would be of more benefit to both Hositals, Covid sufferers, even the big pharma if one thinks about it ( ain’t going to sell meds to dead people).

Unless Silviu has something else solid in the pipeline, writing is on the wall unless MSB or FDA change tact.

Doesn’t make sense.
Im backing Silviu . Here’s hoping a big announcement will come left of field.